DD vs REGN · P/E 127, rev $12.39B vs P/E 14, rev $14.34B
Dupont De Nemours Inc (DD) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Dupont De Nemours Inc (DD) is a specialty chemicals company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported DD revenue for 2024-12-31 was $12.39B. Net income was $738.0M. Revenue was up 2.6% from 2023-12-31 to 2024-12-31. DD currently screens at market cap $19.61B and trailing P/E 127.4.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
DD currently screens at market cap $19.61B and trailing P/E 127.4. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the DD and REGN stock pages for the full models.
Not investment advice.